Date updated:06-25-2007
No description available

-
UNH
Unitedhealth Grou - $28.70
- +0.10%
- $29.00
health

-
WAG
Walgreen Co - $39.37
- +1.23%
- $39.00
drugs

-
HWAY
Healthways - $17.54
- +2.15%
- $17.31
health

-
HAL
Halliburton Co - $29.35
- +0.27%
- $29.63
gas

-
SHLD
Sears Holdings Co - $72.95
- +2.82%
- $71.52
retail

-
WMT
Wal Mart Stores - $54.75
- +0.37%
- $54.85
big sam

-
TGT
Target Cp - $46.78
- +0.47%
- $47.075
bullseye

-
BBY
Best Buy Co Inc - $43.53
- +1.63%
- $43.28
plasma
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Dec. 2, 2009 It’s been a tough year for regional banks. While investors mulled over the fate of the big three banks -- Citigroup (C), Ban...
By Jonas Elmerraji Posted on Dec. 1, 2009 After an earnings season that has brought a significant stream of dividend-increasers, stocks are taking a step back, with jus...
By Roberto Pedone Posted on Dec. 1, 2009 Bullish and Bearish: Each week, Barron’s publishes bullish and bearish stories on a variety of stocks. We present summaries o...
Posted on Dec. 1, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is to gather as much in...
A. The only one I own : SLX,
too hard pick a winner out all of them
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing a... more
Here is the stock list of some of the largest % losers from Dec. 1, 2009. more
Analyst Upgrades for Dec. 2, 2009. Read more here. more













Comments not available